Today, more than 150 million Europeans suffer
from chronic allergic diseases. Up to 20% of patients with allergies live with
a severe debilating form of their condition, and struggle daily with the fear
of a possible asthma attack or even death from an allergic reaction.
Unfortunately, the exact causes of such diseases are not known yet, which makes
it extremely difficult for scientists to develop a cure.
An allergy can be defined as a misguided
reaction to foreign substances, usually harmless, by the immune system. These
substances are called allergens and examples are pollen, dust mites, food,
medicines, etc.
As I am allergic to many things, I know how
irritating and painful an allergic reaction can be. Besides coughing and
sneezing, most people, including myself, also suffer from swollen itchy eyes
and allergic eczema. Unfortunately, up until today, there are only medicines
available that mitigate the pain.
However, there might be a remedy in the future
since scientists at VIB-UGent have managed to unravel the functioning of what
is thought to be the ‘master protein’ that drives a range of widespread
allergic diseases, such as asthma and eczema. Professor Savvides explained that
the protein TSLP, causes inflammation of the white blood cells, which
eventually can lead to an allergic disease. Since they now know how TSLP
functions in the body, Professor Beyaert was able to develop a molecule that
inhibits the functioning of TSLP and thus it functions as an allergy inhibitor.
Now they are still working on the development
of the medicine, but they hope to sell the medicine within 10 years. One thing
is sure, if this medicine works, millions of patients will be grateful to
Professor Savvides and Professor Beyaert.
No comments:
Post a Comment